BP000139-CYT-640: Recombinant Mouse IL-17 A/F Heterodimer
Source: E. coli-derived.
Purity > 97%, by SDS-PAGE.BP000139-CYT-623: Recombinant Human IL-17 A/F Heterodimer
Source: E. coli-derived.
Purity > 98%, by SDS-PAGE.BP000138-CYT-153: Recombinant Rhesus Macaque Interleukin-16 (IL-16) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by its ability to chemoattract human CD4+ T-Lymphocytes using a concentration range of 50.0-100.0 ug/ml corresponding to a Specific Activity of 10,000-20,000 IU/mg.
Purity: > 98.0% by SDS-PAGE.BP000138-CYT-142: Recombinant Human Interleukin-16 (121 a.a.) Protein
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by its ability to chemoattract human CD4+ T-Lymphocytes using a concentration range of 50.0-100.0 ug/ml.
Purity: > 97.0% by RP-HPLC and SDS-PAGE.BP000137-CYT-345: Recombinant Rat Interleukin-15 (IL-15) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of CTLL-2 was found to be < 10 ug/ml, corresponding to a Specific Activity of 100,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000137-CYT-344: Recombinant Mouse Interleukin-15 (IL-15) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of mouse CTLL-2 was found to be 15 ug/ml, corresponding to a Specific Activity of 66,667 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000137-CYT-230: Recombinant Human Interleukin-15 (IL-15) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of mouse CTLL-2 was found to be < 0.5 ug/ml, corresponding to a Specific Activity of 2 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000136-CYT-375: Recombinant Mouse IL-13
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 110 amino acids and having a molecular mass of 12 kDa.
The ED50 range=2-6 ug/ml corresponding to a specific activity of 0.17-0.5 MU/mg, determined by the dose dependent prolifiration of TF-1 cells.
Purity > 95%, by SDS-PAGE.BP000136-CYT-446: Recombinant Human IL-13
Source: E. coli-derived.
The ED50 was determined by the dose dependent prolifiration of TF-1 cells and was found to be < 1 ug/ml, corresponding to a specific activity of 1 MIU/mg.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000136-CYT-489: Recombinant Human IL-13, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS--PAGE and RP-HPLC.